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in contemporary medical practice. In general, performance
profiling has two primary objectives. First, to stimulate and
promote internal quality assurance at the level of the
hospitals and physicians, and, second, to promote an effi-
cient market economy in health care.1
The widely accepted Donabedian’s classic paradigm of
assessing quality of care is based on a three-component
approach; structure, process and outcome.2 Structural
measures refer to inherent characteristics of the provider
that are believed to be associated with quality of care.
Process measures of quality of care reflect the extent to
which a provider complies with evidence-based guidelines.
Postoperative mortality rates serve as an outcome-based
measure to compare hospital quality of surgical care.
However, it has been shown that hospital variations in
mortality rates are not exclusively related to differences in
quality of care but also to differences in case-mix.3e5
Accordingly, Rutherford has emphasised the need for risk-
adjustment for disease severity and other case-mix char-
acteristics for adequately comparing outcomes for vascular
surgery.6 Furthermore, differences in the ascertainment
and definition of data could cause variation in outcome.
Indeed, a study in patients undergoing aortic surgery
concluded that unadjusted mortality rates used as an
indicator of performance are subject to bias and distortion
owing to the collection of incorrect information, variation
in patient selection between hospitals and case-mix
differences.7 Finally, beyond chance, differences in
outcome may reflect genuine differences in structure and
process of care. The association of procedure volume as
a structural measure with outcome is often described in
surgery.8,9 However, less evidence exists regarding the
relation between process of care and outcome in vascular
surgery.
To study whether variation in mortality at hospital level
reflects differences in quality of care, data from the
Netherlands Peripheral Vascular Disease Survey were used,
in which detailed data on patient characteristics, structure
and process of care and outcome are available.
Materials and Methods
Study population
Between May and December 2004, a survey of clinical prac-
tice was conducted in 11 hospitals in the Netherlands.10 This
surveywas an integral part of the infrastructure of the survey
programme supported by the Netherlands Heart Foundation
in the context of the Euro Heart Survey Programme. The
objective of the Euro Heart Survey was to evaluate clinical
practice, adherence to guidelines, differences in the
management and outcome of patients and to assess to whatextent the patients of daily practice are represented in
randomised clinical trials. Five hospitals were located in the
centre part of the country, three hospitals in the northern
region and three in the southern region. The participating
sites included two small centres (<400 beds), five of inter-
mediate size (400e800 beds) and four large centres (>800
beds). Two centres were university hospitals, which act as
tertiary referral centres.
Patients undergoing peripheral vascular repair were
eligible for participation in the survey. All consecutive
patients included in this survey were seen at the partici-
pating vascular surgery departments and were undergoing
non-cardiac vascular repair (endovascular or open proce-
dures). Endovascular procedures included aortic endograft
procedures and peripheral angioplasties with and without
stenting. Open procedures included: elective abdominal
aortic surgery, carotid endarterectomy or infrainguinal
arterial reconstruction. The total study population con-
sisted of 711 consecutively enrolled patients. The 11
hospitals were divided into three clusters, and in every
cluster the predetermined number of patients were
consecutively included during the time period.
The medical ethics committees of the participating
hospitals approved the study. All patients provided
informed consent.
Data collection
Trained research assistants obtained data on patient char-
acteristics, diagnostic procedures, cardioprotective treat-
ment and the surgical procedure from the patients’ hospital
charts. All data were entered into the electronic Case
Record Form (eCRF) and transferred regularly to the central
database at Erasmus MC via the Internet. Data entered into
the eCRF were automatically checked for completeness,
internal consistency and accuracy. The data management
staff at Erasmus MC performed additional edit checks. If
necessary, queries were resolved with the local research
assistants. At 1 year and 3 years, survival status was
obtained through the Civil Registries. Follow-up was
complete in 98.5%. More details on the study population
and methods of data collection can be found in an earlier
publication on this survey.10
Clinical characteristics
We determined the cardiac risk score for each patient in
our data set, according to the Lee index,11 and one point
was assigned to each of the following characteristics: open
vascular surgery, history of ischaemic heart disease, history
of congestive heart failure, history of cerebrovascular
disease, insulin therapy for diabetes mellitus and renal
insufficiency. Hypertension was recorded if patients
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patients were medically treated for hypertension. Diabetes
mellitus was recorded if patients presented with a fasting
glucose level 7.0 mmol l1, or in those who required
treatment. Renal insufficiency was recorded if patients
presented with a serum creatinine level 2.0 mg dl1 or in
those who required dialysis. Obesity was defined as having
a body mass index (BMI) 30.
Structure of care
Structural measures refer to inherent characteristics of the
provider that are believed to be associated with quality of
care. High volume, university centre and preoperative
anaesthesiology outpatient clinic were used as structural
measures for quality of care in this study. The volume of
abdominal aortic aneurysm procedures per hospital
assessed volume of the hospitals in 2004 and high volume
was defined as more than 80 procedures per year.12
Process of care
Process measures of quality of care reflect the extent to
which a provider complies with evidence-based guidelines.
The American College of Cardiology/American Heart Asso-
ciation (ACC/AHA) guidelines for perioperative care were
the guided choice for quality of care parameters in this
survey.13 These parameters included non-invasive testing,
beta-blocker therapy, anti-platelet therapy and choles-
terol-lowering therapy. Application of all recommended
procedures and treatments were derived from the hospital
records. When nothing was reported in the hospital record,
the procedure or treatment was considered as not applied.
Outcome measures
Mortality was reported at 30 days, 1 year and 3 years after
surgery. We defined 1-year all-cause mortality as the
primary end point in this study. Sensitivity analyses were
performed with the alternative outcome measures.
Statistical analyses
To assess the differences in outcome between hospitals in
patient characteristics, structure of care and process of
care, hospitals were divided in tertiles based on the
percentage of patients who died in the first year. Dichoto-
mous data are described as numbers and percentages, andTable 1 Variation in percentage 1-year mortality by hospital.
Hospital Tertiles ba
Total 1 (lowest)
Number of patients 711 300
Number of hospitals 11 3
30-day mortality 28 (4%) 4% (2e5)
1-year mortality 77 (11%) 8% (6e9)
3-year mortality 149 (21%) 18% (11e22)
a Hospitals were divided into tertiles based on the percentage of pacontinuous data are presented as means with standard
deviations (SD). Differences in patient characteristics,
structure of care, process of care and outcome between
hospitals were evaluated by analysis of variances (ANOVAs)
and chi-square tests, where appropriate.
Stepwise logistic regression analysis was performed to
investigate the relationship between clinical characteris-
tics, structure of care, process of care and outcome. The
database has a hierarchical structure with patients oper-
ated in different hospitals. To account for the different
sources of variation (patient level and centre level) in
observed mortality rates at different centres, we used
a multilevel model with hospital as a random effect. In the
first step of the multilevel model, we included only age, sex
and the Lee index. Second, other clinical characteristics
were added: obesity, smoking, hypertension, arrhythmia,
valvular disease and chronic obstructive pulmonary disease
(COPD). Type of vascular surgery (abdominal, carotid and
peripheral) was also added in this step. Structural measures
were added in the third step. In the final step, selected
processes of care were added to the model. The contribu-
tion of each step was expressed by Akaike’s information
criterion (AIC), which corresponds to the c2 of the step (or
the difference in 2 log likelihood between the model with
and without that step) minus 2 the degrees of freedom.14
Analysis was performed using SPSS 14.0 for Windows and R
statistical software. Multilevel regression models were
constructed with the Laplace method using the LME4
package of R. For all tests, a p-value< .05 (two-sided) was
considered significant.
Results
Outcome
The study population consisted of 711 patients undergoing
vascular repair. Of all patients, 4% died during hospital stay
(Table 1). At 1 year, 77 patients died (11%), ranging from 6%
to 26% between hospitals (Fig. 1). The mean mortality rate
was 8% in tertile 1, 11% in tertile 2 and 17% in tertile 3. A
total of 149 (21%) patients died within 3 years of follow-up.
Clinical characteristics
The mean age was 67 years (SDZ 10) and 70% were male.
Half of the patients underwent an endovascular procedure
(nZ 354), 328 patients (46%) had open surgery and 29
patients (4%) underwent carotid endarterectomy. Of thesed on patient outcome (% dead at 1 year)a
2 3 (highest)
247 164
4 4
3% (1e7) 5% (0e11)
11% (10e11) 17% (13e26)
21% (17e25) 28% (24e37)
tients that were dead at 1 year.
Figure 1 One-year mortality after vascular repair by hospital
and tertile division.
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one, 31% had two risk factors and 8% had three or more risk
factors according to the Lee index. Differences in clinical
characteristics between the hospital tertiles were observed
(Table 2). For example, percentage males varied from 72%
to 67% (p< 0.05) and percentage patients with good func-
tional capacity from 70% to 60% (p< 0.05). The percentageTable 2 Variation in patient characteristics by hospital.
Hospital Tertiles b
Total 1 (lowest)
Number of patients 711 300
Number of hospitals 11 3
Age> 70 299 (42%) 40% (28e46)
Male gender 496 (70%) 72% (56e79)
Current smoker 256 (36%) 35% (28e46)
Hypertension 273 (38%) 31% (2e70)
Diabetes Mellitus 149 (21%) 21% (20e22)
Renal insufficiency 51 (7%) 8% (2e10)
Angina pectoris 99 (14%) 12% (10e16)
Myocardial infarction 106 (15%) 17% (14e18)
Heart failure 38 (5%) 5% (4e6)
Stroke or TIA 123 (17%) 16% (6e18)
Previous revascularisation 116 (16%) 20% (9e26)
COPD 101 (14%) 10% (2e12)
Good functional capacity 471 (66%) 71% (65e73)
Open surgical procedure 357 (50%) 47% (20e56)
Elective procedure 619 (87%) 82% (75e96)
Lee-Indexb
0 187 (26%) 28% (18e46)
1 243 (34%) 33% (27e41)
2 221 (31%) 31% (11e38)
 3 60 (8%) 9% (2e12)
COPD, chronic obstructive pulmonary disease.
a Hospitals were divided into tertiles based on the percentage of p
b Variables included in the Lee-Index; open surgical procedure, ischa
cerebrovascular disease, diabetes mellitus and renal insufficiency.
c c2 for differences between 11 hospitals.patients with no risk factors ranged from 28% in the lowest
tertile to 24% in the highest tertile. The percentage of high-
risk patients (two or more risk factors) varied between
hospitals from 13% to 63% (p< 0.001) as illustrated in Fig. 2.
Across the tertiles of hospital mortality, these percentages
were 40%, 39% and 40%, respectively (pZ 0.959). Half of
the patients underwent an open surgical procedure. The
357 open vascular procedures included infrainguinal arte-
rial reconstruction (52%), abdominal aortic surgery (42%)
and 21 (6%) other procedures. The percentage of patients
undergoing open surgical procedure varied also widely
between the centres (20e100%, p< 0.001).
Structure of care
Of the participating 11 hospitals, three hospitals were
defined as high-volume hospitals (>80 procedures per year)
and eight hospitals had a preoperative anaesthesiology
outpatient clinic (Table 3). These structure measures were
equally distributed among the tertiles. The two-university
hospitals had both an intermediate mortality rate.
Process of care
Although 185 of the total 711 patients (26%) fulfilled theACC/
AHA guideline criteria to recommend preoperative non-
invasive cardiac testing, clinicians had performed testing inased on patient outcome(% dead at 1 year)a
2 3 (highest) p-Valuec
247 164
4 4
42% (39e49) 46% (38e58) ns
69% (65e73) 67% (49e90) <.05
35% (28e49) 40% (26e47) <.05
53% (2e81) 31% (21e74) <.001
21% (17e31) 21% (15e26) ns
7% (3e12) 7% (2e21) <.05
16% (12e20) 15% (10e21) ns
13% (12e15) 14% (10e21) ns
8% (2e13) 3% (0e5) ns
16% (2e29) 23% (15e28) <.05
17% (12e20) 9% (3e16) <.05
20% (16e29) 14% (11e21) <.05
65% (37e90) 60% (46e76) <.001
47% (36e81) 60% (43e100) <.001
90% (85e96) 91% (84e100) <.001
<.001
26% (15e31) 24% (0e37)
35% (28e47) 35% (27e47)
30% (18e38) 32% (23e47)
9% (7e15) 8% (5e16)
atients that were dead at 1 year.
emic heart disease, history of congestive heart failure, history of
Figure 2 Variation in patient characteristics and process of care parameters by hospital and mortality based tertile division.
Process of Care Explains Variation in Mortality 151only 38 of those cases (21%). As shown in Table 4, this
percentage varied from 12% to 30% across the hospital ter-
tiles (pZ 0.06). In general, 304 patients (48%) receivedbeta-
blocker therapy, 398 patients (56%) statin therapy and 575
patients (81%) anti-platelet therapy in the perioperative
period. These proportions differed significantly between the
hospital tertiles: 52e34% for beta-blockers (p< 0.001) and
60e48% for statins (pZ 0.039). The percentage of beta-
blocker users in the 281 high-risk patients, that is, 2 risk
factors according to the Lee index, was 62%. This proportion
varied also widely across the hospitals tertiles in the same
trend as the overall proportions (68e52%, pZ 0.084).
Relation between clinical characteristics, quality of
care and outcome
Age, sex and the Lee index explained a large part of
the variation in mortality (step 1; AICZ 59, p< 0.001)Table 3 Variation in structure of care by hospital.
Hospit
Total 1 (low
Number of patients 711 300
Number of hospitals 11 3
High-volume hospital 3 1
Preoperative anaesthesiology outpatient clinic 8 2
University hospital 2 0
a Hospitals were divided into tertiles based on the percentage of pa
b c2 for differences in presence of structure of care parameter betw(Table 5(a)). A relatively small part was explained by
other risk factors (step 2; AIC Z 1, pZ 0.102). After
adjusting for all these risk factors in steps 1 and 2,
structure of care explained a non-significant part of the
variation on mortality (step 3; AICZ4, pZ 0.285). By
contrast, on top of clinical characteristics and structural
measures, process measures of quality of care explained
a relatively large part of the variation in mortality (step 4;
AICZ 5, pZ 0.001). The area under the curve of the model
with only age, sex and the Revised Cardiac Risk Index
was .74 and increased to .81 for the complete model.
Sensitivity analyses
Results were not affected by changing the dependent
variable of the logistic regression analysis into 30-day
mortality (Table 5(b)). Step 1 and 4 explained most of the
variation in mortality (AICZ 44, p< 0.001 and AICZ 16,al Tertiles based on outcome (% dead at 1 year)a
est) 2 3 (highest) p-Valueb
247 164
4 4
1 1 <.001
3 3 <.001
2 0 <.001
tients that were dead at 1 year.
een 11 hospitals.
Table 4 Variation in process of care by hospital.
Hospital Tertiles based on outcome (% dead at 1 year)a
Total 1 (lowest) 2 3 (highest) p-Valueb
Number of patients 711 300 247 164
Number of hospitals 11 3 4 4
Diagnostic investigations
Non-invasive test 38/185 (21%) 22% (0e55) 12% (0e35) 30% (20e33) <.05
Medical therapy
Beta-blockers 340 (48%) 52% (33e61) 52% (35e77) 34% (21e45) <.001
In high-risk patients 174/281 (62%) 68% (57e71) 62% (39e87) 52% (39e69) <.05
Statins 398 (56%) 60% (33e73) 57% (37e78) 48% (41e68) <.001
In high-risk patients 180/281 (64%) 67% (43e77) 63% (39e78) 61% (56e67) ns
Anti-platelet therapy 575 (81%) 81% (77e83) 78% (37e88) 85% (68e97) <.05
a Hospitals were divided into tertiles based on the percentage of patients that were dead at 1 year.
b c2 for differences between 11 hospitals.
152 S.E. Hoeks et al.pZ 0.003). Consistent results were obtained with 3-year
mortality.
Discussion
In this survey, we observed large variations in patient
characteristics, quality of process and structure of care and
mortality. Even after adjusting for the patient population at
risk, a substantial part of the variation in mortality
between hospitals can be explained by differences in
process of care.
In recent years, more attention is given to relating
structure and process of care to outcome. Literature
reveals diverse conclusions regarding the association of
process and outcome in different subsets of patients. For
example, in stroke patients, the considerable variation in
patient outcome, which was observed between hospitals,
could not be explained by the differences in quality of
process of care.15,16 Mainly differences in case-mix
contributed to the observed variation in patient outcome.
On the other hand, a recent study in acute coronary
syndrome patients showed a significant association
between process of care and outcomes.17 Their study used
nine ACC/AHA guideline recommendations to assess
whether composite adherence was related to adjusted in-
hospital mortality. In this article, the 2002 ACC/AHA
guideline recommendations outlining diagnostic and ther-
apeutic interventions for patients undergoing non-cardiac
surgery were used to select process of care measures.13 OurTable 5a Multilevel stepwise logistic analysis: Predictors
of 1-year mortality.
Contribution of each step
c2 Df AIC* p-Value
Step 1: Age, sex and Lee-index 69 5 59 <.001
Step 2: Risk factors 11 6 1 .102
Step 3: Structure of care 2 3 4 .285
Step 4: Process of care 13 4 5 .001
* Akaike’s Information Criterion.study demonstrated a significant association between
process of care and patient outcome.
Process of care in terms of adherence to guideline
criteria seems logical to serve as a marker of quality of
care.18e20 Difficulties arise, however, when the evidence
for diagnostics and treatment is less clear, as is the case for
the guidelines on perioperative care. Recently, new
guidelines have been published in this area.21e23 These new
guidelines do strengthen the recommendation of statins
and a modified careful use of beta-blockers in vascular
surgery patients.24,25 Highly evidence-based and well-
formulated guidelines are fundamental for good
implementation.
Second, although randomised controlled trials have
shown effectiveness of guideline recommendations in
selected patients and controlled settings, few data are
available regarding the performance of these quality
measures in daily clinical practice. Furthermore, it is
known that disparity exists between patients in clinical
practice and patients in whom the studies that provide the
evidence for treatment guidelines are performed.26 Third,
the choice of process measure should be relevant. For
example, a recent study examined the association of
performance measures and clinical outcomes for patients
hospitalised with heart failure but found little relationship.
They claimed that additional measures such as beta-
blocker therapy at hospital discharge may be required to
more effectively quantify the quality of care provided to
these patients.27 Fourth, studies reported lack of strong
correlation between several individual processTable 5b Multilevel stepwise logistic analysis: Predictors
of 30-day mortality.
Contribution of each step
c2 Df AIC* p-Value
Step 1: Age, sex and Lee-index 44 5 34 <.001
Step 2: Risk factors 5 6 7 .554
Step 3: Structure of care 2 3 4 .438
Step 4: Process of care 16 4 8 .003
* Akaike’s Information Criterion.
Process of Care Explains Variation in Mortality 153measures.17,28 For example, modest correlation was
observed between the use of aspirin and beta-blockers at
discharge in patients with acute coronary syndromes.17
These results emphasise the need for accurately identi-
fying a broad range of quality indicators.
The association between the structural component
volume and outcome is often investigated in surgical care.
For example, in abdominal aortic aneurysm surgery, several
studies described an inverse volumeeoutcome effect rela-
tionship.8,9 By contrast, we did not observe a relation
between volume and outcome. Shackley et al. demon-
strated that adjusting for case-mix tends to diminish the
relationship between volume and outcome in peripheral
vascular surgery, which might also explain our results.29
Other explanations for this could be the small number of
included hospitals and patients in our study. Furthermore,
the included surgical procedures could be too heteroge-
neous. In addition, the definition of high volume of
abdominal aortic aneurysm operations, which we used in
our study, may be not a good indicator for the volume
effect. Furthermore, as argued by others, the vascular
procedures could be too heterogeneous to detect real
differences. However, it has to be noticed that volume is
clearly a proxy measure for other characteristics because
there exists no direct link between volume and outcome.
For example, in a study including myocardial infarction
patients, differences in process of care explained one-third
of the survival advantage attributed to high-volume hospi-
tals.30 Evidence regarding the underlying explanations is
not well investigated. With regard to quality improvement,
it is also important to note that structural measures are
difficult to change, while the key advantage of process
measures is the relatively actionable nature.31 Our results
indicate the urge for improving and evaluating process of
care at hospital level as we observed a clear relationship
between these quality measures and mortality in patients
undergoing vascular surgery. Effective quality improvement
efforts such as benchmarking of hospitals on process
measures such as beta-blockers and statins are necessary to
increase quality of care in low-performance hospitals.32
Using 1-year mortality as the primary end point in this
study might be a point of discussion. Importantly, sensi-
tivity analyses using 30-days and 3-year mortality did not
change the observed relationship between process of care
and outcome. These results strengthen the role of process
indicators in vascular surgery demonstrated in this study. In
the era of increasing pay-for-performance and focus on
measurement of quality of care, future research is needed
to establish accurate and valid performance measures in
vascular surgery.
In conclusion, we observed that patient outcome varies
widely between hospitals. A substantial part of this
observed variation in mortality was explained by differ-
ences in process of care, on top of patient characteristics.
An important implication of these results is that improve-
ment of patient outcome per hospital can be achieved by
targeting process of care parameters.Conflict of Interest
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